DekaBank Deutsche Girozentrale
CLVS

DekaBank Deutsche Girozentrale’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,000
Closed -$124K 1511
2021
Q3
$124K Hold
28,000
﹤0.01% 1281
2021
Q2
$160K Hold
28,000
﹤0.01% 1267
2021
Q1
$187K Hold
28,000
﹤0.01% 1193
2020
Q4
$123K Buy
+28,000
New +$123K ﹤0.01% 1254
2020
Q1
Sell
-8,389
Closed -$95K 1178
2019
Q4
$95K Sell
8,389
-18,600
-69% -$211K ﹤0.01% 1048
2019
Q3
$108K Sell
26,989
-18,600
-41% -$74.4K ﹤0.01% 906
2019
Q2
$616K Buy
45,589
+21,256
+87% +$287K ﹤0.01% 887
2019
Q1
$871K Buy
24,333
+3,700
+18% +$132K 0.01% 802
2018
Q4
$371K Sell
20,633
-3,700
-15% -$66.5K ﹤0.01% 878
2018
Q3
$871K Buy
24,333
+583
+2% +$20.9K 0.01% 819
2018
Q2
$1.07M Hold
23,750
0.01% 729
2018
Q1
$1.26M Sell
23,750
-24,050
-50% -$1.27M 0.01% 663
2017
Q4
$3.43M Hold
47,800
0.03% 449
2017
Q3
$3.43M Buy
47,800
+15,000
+46% +$1.08M 0.03% 454
2017
Q2
$3.02M Hold
32,800
0.02% 469
2017
Q1
$2.06M Buy
32,800
+8,100
+33% +$509K 0.02% 481
2016
Q4
$1.1M Buy
24,700
+1,900
+8% +$84.3K 0.01% 524
2016
Q3
$790K Hold
22,800
0.01% 588
2016
Q2
$343K Buy
22,800
+6,300
+38% +$94.8K ﹤0.01% 757
2016
Q1
$317K Sell
16,500
-2,900
-15% -$55.7K ﹤0.01% 745
2015
Q4
$667K Buy
19,400
+200
+1% +$6.88K 0.01% 633
2015
Q3
$1.77M Buy
19,200
+2,650
+16% +$244K 0.02% 465
2015
Q2
$1.45M Buy
16,550
+600
+4% +$52.7K 0.02% 502
2015
Q1
$1.18M Sell
15,950
-2,250
-12% -$167K 0.01% 544
2014
Q4
$1M Sell
18,200
-1,700
-9% -$93.8K 0.01% 560
2014
Q3
$903K Buy
19,900
+400
+2% +$18.2K 0.01% 532
2014
Q2
$807K Sell
19,500
-1,300
-6% -$53.8K 0.01% 531
2014
Q1
$1.44M Buy
20,800
+1,450
+7% +$100K 0.02% 420
2013
Q4
$1.14M Buy
19,350
+2,500
+15% +$147K 0.02% 411
2013
Q3
$1.02M Buy
16,850
+3,550
+27% +$216K 0.02% 426
2013
Q2
$905K Buy
+13,300
New +$905K 0.02% 383